Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. The company's products include Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder, Brovana (arformoterol tartrate) inhalation solution, Latuda (lurasidone HCI) and Aptiom (eslicarbazepine acetate). Headquartered in Marlborough, Mass., Sunovion is an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion Pharmaceuticals Canada Inc., based in Mississauga, Ontario, are wholly-owned direct subsidiaries of Sunovion Pharmaceuticals Inc.
Reaching 40 million women each month (Nielsen Site Census, April 2012), BlogHer (http://www.blogher.com) is the leading cross-platform media network created by, for and with women social media leaders. BlogHer developed and leads the marketplace with the most robust economic and networking opportunities for women in social media and brands seeking to engage in authentic and persuasive dialog with them. Founded in February 2005 by Elisa Camahort Page, Jory Des Jardins and Lisa Stone, BlogHer publishes and syndicates news, information, advice and recommendations to and from 3,000 premium blogs, delivers uniquely insightful research on women in social media across interest areas, hosts the world's largest conferences for women in social media and curates a daily news service, BlogHer.com.